After halting a CYP3A4 inducer, since the effects in the inducer decrease, the buprenorphine plasma concentration will maximize [see CLINICAL PHARMACOLOGY], which could boost or prolong both therapeutic effects and adverse reactions and will cause severe respiratory depression.Caution patients that SUBUTEX may impair the psychological or physical a